Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 18, 2009

Premium

Christian Henry has been named vice president of corporate development at Illumina, the company said this week.

In this newly created position, Henry will be responsible for all activities related to corporate and business development, strategic planning, and mergers and acquisitions, Illumina said.

Henry has served as Illumina's chief financial officer since 2005. Before that he held positions at Tickets.com and Affymetrix. The San Diego company said it is now searching for a new CFO.


Several Nanogen executives resigned last week, a month after the firm sold its assets to Elitech for $25.7 million. The resignations were authorized by the United States Bankruptcy Court for the District of Delaware.

The resignations included Chairman Howard Birndorf, who resigned as CEO last month, and board members David Schreiber, Robert Whalen, Stelio Papadopoulos, and Heiner Dreismann.

In addition, Graham Lidgard resigned as senior vice president of R&D, while David Ludvigson, who served as the president and chief operating officer of the company prior to the issuance of the court's order, was appointed to serve as the president and secretary of Nanogen. Nicholas Venuto, who served as chief financial officer of the firm prior to the order, was re-appointed CFO, according to the firm's SEC filing.


Millipore has named John Sweeney to be vice president of its Life Science business unit. Sweeney recently was VP of strategy and marketing services for Millipore's Bioscience Division, and he joined the company in 2003 as director of strategy and corporate development.


Joan Wilson has joined the Marshall University Institute for Interdisciplinary Research in Miami as a senior scientist, the institute said.

Wilson was most recently a researcher at System Biosciences. Before that, she was a senior applications scientist and product manager with Panomics, now Affymetrix, and a research fellow at the Harvard Institute of Proteomics.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.